Malaria, Vivax: all 105 studies
Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Tafenoquine Drug Levels in Small ChildrenNot yet recruitingNCT07835321Phase 2
- Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 YearsNot yet recruitingNCT07831226Phase 1
- Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium VivaxNot yet recruitingNCT07533136Not applicable
- Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.RecruitingNCT07468513Phase 4
- This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax MalariaNot yet recruitingNCT07430592Phase 2
- Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated MalariaNot yet recruitingNCT07403643Phase 4
- Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, ColombiaNot yet recruitingNCT07373301Phase 2
- Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."Not yet recruitingNCT07172724Phase 1
- Tafenoquine and ACTs (TADORE- Plus)Not yet recruitingNCT07060794Phase 4
- Postpartum 8-aminoquinoline Breast Milk StudyNot yet recruitingNCT07060404Phase 2/3
- Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean ChildrenRecruitingNCT07052162Phase 4
- Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarRecruitingNCT06923592Phase 3
- An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and OlderRecruitingNCT06666491Phase 3
- A Revised Tafenoquine Dose to Improve Radical Cure for Vivax MalariaRecruitingNCT06148792Phase 3
- ACT vs CQ With Tafenoquine for P. Vivax Mono-infectionRecruitingNCT05788094Phase 4
- FocaL Mass Drug Administration for Vivax Malaria EliminationRecruitingNCT05690841Phase 3
- Southeast Asia Dose Optimization of TafenoquineRecruitingNCT04704999Phase 4
- Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 VaccineTerminatedNCT05270265Early Phase 1Results posted
- Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax MalariaCompletedNCT04709692Phase 2Results posted
- Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical CureCompletedNCT04706130Phase 4Results posted
- Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax MalariaTerminatedNCT04368910Phase 3Results posted
- TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014CompletedNCT04222088Results posted
- Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1CompletedNCT04201431Phase 1/2Results posted
- VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP VaccinesCompletedNCT04009096Phase 2Results posted
- VAC069: A Study of Blood-stage Controlled Human P. Vivax InfectionCompletedNCT03797989Early Phase 1Results posted
- Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, BrazilCompletedNCT03610399Not applicableResults posted
- Assessing a Risk Model for G6PD DeficiencyTerminatedNCT03337152Phase 4Results posted
- Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02802501Phase 3Results posted
- A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02563496Phase 2Results posted
- Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax MalariaCompletedNCT02216123Phase 3Results posted
- Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectionCompletedNCT01753323Phase 2Results posted
- Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax RelapseCompletedNCT01376167Phase 2Results posted
- Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infectionCompletedNCT01213966Phase 2Results posted
- Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve AdultsCompletedNCT01157897Phase 1/2Results posted
- Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax MalariaCompletedNCT00440999Phase 3Results posted
- Efficacy of Chloroquine-Primaquine Treatment for Uncomplicated Plasmodium Vivax MalariaCompletedNCT07753967Not applicable
- Vivax Elimination With Tafenoquine (VET) StudyCompletedNCT06575647Phase 4
- Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium VivaxCompletedNCT06044805Phase 4
- Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West PapuaCompletedNCT06036030Phase 2
- TES of Chloroquine for Pv in the Philippines in 2016CompletedNCT05958797
- Short Course Primaquine for the Radical Cure of P. Vivax Malaria - IndonesiaCompletedNCT05879224Not applicable
- Short Course Primaquine for the Radical Cure of P. Vivax - Papua New GuineaCompletedNCT05874271Not applicable
- Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in ThailandCompletedNCT05753150
- Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese ShieldCompletedNCT05540470Not applicable
- Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in PeruCompletedNCT05361486
- Primaquine Double Dose for Radical Cure of Plasmodium Vivax in ColombiaWithdrawnNCT05232227Phase 2/3
- Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in BrazilActive, not recruitingNCT05096702
- Plasmodium Vivax Among Duffy Negative Population in Cameroon.Status unknownNCT05058885
- Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in ThailandCompletedNCT05052502Not applicable
- Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in ChildrenCompletedNCT05044637Phase 2
- Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune VolunteersStatus unknownNCT04739917Phase 2
- Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic RepublicWithdrawnNCT04416945Not applicable
- Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and PrimaquineCompletedNCT04411836Phase 3
- Biomarkers of P. Vivax RelapseStatus unknownNCT04228315Not applicable
- Serological Screen and Treat Trial for Plasmodium VivaxStatus unknownNCT04223674Not applicable
- Short Course Radical Cure of P. Vivax Malaria in NepalCompletedNCT04079621Phase 4
- Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic AreasCompletedNCT03916003Phase 4
- Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient PatientsCompletedNCT03529396Phase 2
- Study of Controlled Human Plasmodium Vivax InfectionCompletedNCT03377296Not applicable
- A Retrospective Study of Severe Plasmodium VivaxCompletedNCT03307369
- DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in BrazilCompletedNCT03208907Phase 3
- G6PD Assessment Before Primaquine for Radical Treatment of Vivax MalariaCompletedNCT02876549Phase 4
- A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled SolutionCompletedNCT02751294Phase 1
- Methylene Blue Against Vivax Malaria in EthiopiaWithdrawnNCT02696928Phase 2
- Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax InfectionCompletedNCT02691910Phase 2/3
- Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)CompletedNCT02658435Phase 1
- Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in MalaysiaStatus unknownNCT02348788Phase 3
- A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine TetraphosphateCompletedNCT02184637Phase 1
- DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or VivaxCompletedNCT02123290Phase 2
- Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:CompletedNCT02118090Phase 4
- Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax MalariaTerminatedNCT02110784Phase 2
- Malaria in Early Life StudyCompletedNCT02001428Not applicable
- Tafenoquine Thorough QTc Study in Healthy SubjectsCompletedNCT01928914Phase 1
- Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in VietnamCompletedNCT01887821Phase 4
- IMPROV (Improving the Radical Cure of Vivax Malaria)CompletedNCT01814683Not applicable
- Parasitic Clearance and Recurrence Rates Among Patients With Vivax MalariaStatus unknownNCT01784315
- Primaquine Pharmacokinetics in Lactating Women and Their InfantsCompletedNCT01780753Phase 1
- Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in BhutanCompletedNCT01716260
- Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in ThailandStatus unknownNCT01662700Phase 4
- Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)CompletedNCT01640574Phase 3
- Artemether/Lumefantrine and Vivax MalariaCompletedNCT01625871Phase 3
- Chloroquine Population Pharmacokinetics in Pre and Post-partum WomenCompletedNCT01546961Not applicable
- Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectionCompletedNCT01524341Phase 2
- Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax MalariaCompletedNCT01288820Phase 3
- Pharmacokinetic Study of Primaquine and Chloroquine in Healthy SubjectsCompletedNCT01218932Phase 1
- Estimating the Risk of Plasmodium Vivax Relapses in AfghanistanCompletedNCT01178021Phase 4
- Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)TerminatedNCT01107145Phase 4
- Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human VolunteersCompletedNCT01083095Early Phase 1
- Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two AdjuvantsCompletedNCT01081847Phase 1
- Incidence of Vivax Along the Thai Burma BorderCompletedNCT01076868Not applicable
- Study on the Treatment of Vivax MalariaCompletedNCT01074905Phase 3
- Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian AmazonCompletedNCT00951106Not applicable
- Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in HumansCompletedNCT00935623Phase 1
- Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium VivaxCompletedNCT00811096Phase 2
- A Comparative Study of Artekin With Standard Malarial Treatment Regimes in AfghanistanCompletedNCT00682578Phase 3
- Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaCompletedNCT00486694Phase 2
- PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for MalariaCompletedNCT00295581Phase 1
- Prevention of P. Vivax Malaria During Pregnancy in BoliviaWithdrawnNCT00290420Phase 4
- Eight Week Primaquine Regimen for the Treatment of Vivax MalariaCompletedNCT00158587Phase 3
- Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax MalariaCompletedNCT00158561Phase 3